Christine Lind
Vorstandsvorsitzender bei BACTIGUARD HOLDING AB
Vermögen: 19 675 $ am 30.04.2024
Aktive Positionen von Christine Lind
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| XSPRAY PHARMA AB | Direktor/Vorstandsmitglied | 01.01.2019 | - |
| Independent Dir/Board Member | 01.01.2019 | - | |
| MENDUS AB | Independent Dir/Board Member | 01.01.2020 | - |
| Vorsitzender | 22.01.2021 | - | |
| Direktor/Vorstandsmitglied | 01.01.2020 | 22.01.2021 | |
| BACTIGUARD HOLDING AB | Vorstandsvorsitzender | 12.04.2024 | - |
Lind Growth Strategy AB
 Lind Growth Strategy AB Miscellaneous Commercial ServicesCommercial Services Lind Growth Strategy AB is a private company that provides life science consulting services. The CEO of the Swedish company is Christine Lind. | Vorsitzender | 01.03.2019 | - |
| Vorstandsvorsitzender | - | - | |
| Direktor/Vorstandsmitglied | - | - | |
NDA Group AB
 NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Corporate Officer/Principal | 01.04.2021 | - |
| Shinka Life Sciences AB | Corporate Officer/Principal | - | - |
Karriereverlauf von Christine Lind
Ehemalige bekannte Positionen von Christine Lind
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MEDIVIR AB | Vorstandsvorsitzender | 01.04.2017 | 15.10.2018 |
| Corporate Officer/Principal | 01.03.2015 | 01.04.2017 | |
| Präsident | - | 15.10.2018 | |
| BIOARCTIC AB | Corporate Officer/Principal | 01.01.2019 | - |
| Medivir Personal AB | Direktor/Vorstandsmitglied | - | - |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Christine Lind
| Columbia Business School | Masters Business Admin |
| The Leonard N Stern School of Business | Undergraduate Degree |
Statistik
International
| Schweden | 11 |
| Vereinigte Staaten | 4 |
Operativ
| Corporate Officer/Principal | 5 |
| Director/Board Member | 5 |
| Chief Executive Officer | 3 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| MEDIVIR AB | Health Technology |
| XSPRAY PHARMA AB | Health Technology |
| MENDUS AB | Health Technology |
| BIOARCTIC AB | Health Technology |
| BACTIGUARD HOLDING AB | Health Technology |
| Private Unternehmen | 6 |
|---|---|
LifeCell Corp.
 LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
| Glycovisc BioTech AB | |
Lind Growth Strategy AB
Lind Growth Strategy AB Miscellaneous Commercial ServicesCommercial Services Lind Growth Strategy AB is a private company that provides life science consulting services. The CEO of the Swedish company is Christine Lind. | Commercial Services |
| Medivir Personal AB | |
NDA Group AB
NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Commercial Services |
| Shinka Life Sciences AB |
- Börse
- Insiders
- Christine Lind
- Erfahrung
